NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases

Due to their potent immunoregulatory and angio-modulatory properties, mesenchymal stem cells (MSCs) and their exosomes (MSC-Exos) have emerged as potential game-changers in regenerative ophthalmology, particularly for the personalized treatment of inflammatory diseases. MSCs suppress detrimental imm...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Carl Randall Harrell, Valentin Djonov, Ana Antonijevic, Vladislav Volarevic
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Subjects:	NLRP3 inflammasome mesenchymal stem cell exosomes therapy inflammatory eye diseases
Online Access:	https://www.mdpi.com/2073-4409/12/18/2327